v3.22.2.2
Share-Based Compensation Expenses (Details) - Schedule of summary of share option activity - ¥ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Share Incentive Plan 2018 [Member]              
Share-Based Compensation Expenses (Details) - Schedule of summary of share option activity [Line Items]              
Number of shares balance (in Shares)       187,933,730 187,933,730 187,933,730
Weighted average exercise price balance      
Weighted average grant date fair value balance       ¥ 1.27 ¥ 1.27 ¥ 1.27
Number of shares granted exercisable (in Shares)       187,933,730 150,346,984 112,760,238  
Weighted average exercise price exercisable        
Weighted average grant date fair value exercisable       ¥ 1.27 ¥ 1.27 ¥ 1.27  
Number of shares granted expected to vest (in Shares)       37,586,746 75,173,492  
Weighted average exercise price expected to vest        
Weighted average grant date fair value expected to vest       ¥ 1.27 ¥ 1.27  
Number of shares granted (in Shares)         187,933,730
Weighted average exercise price granted        
Weighted average grant date fair value granted         ¥ 1.27
Number of shares granted exercised (in Shares)        
Weighted average exercise price exercised        
Weighted average grant date fair value exercised        
Number of shares granted surrendered (in Shares)        
Weighted average exercise price surrendered        
Weighted average grant date fair value surrendered        
Share Incentive Plan 2019 [Member]              
Share-Based Compensation Expenses (Details) - Schedule of summary of share option activity [Line Items]              
Number of shares balance (in Shares) 119,674,780 119,674,780 119,674,780 119,674,780    
Weighted average exercise price balance    
Weighted average grant date fair value balance ¥ 0.72 ¥ 0.72 ¥ 0.72 ¥ 0.72    
Number of shares granted exercisable (in Shares) 95,739,824 95,739,824        
Weighted average exercise price exercisable        
Weighted average grant date fair value exercisable ¥ 0.72 ¥ 0.72        
Number of shares granted expected to vest (in Shares) 23,934,956 23,934,956   119,674,780      
Weighted average exercise price expected to vest        
Weighted average grant date fair value expected to vest ¥ 0.72 ¥ 0.72   ¥ 0.72      
Number of shares granted (in Shares)     119,674,780    
Weighted average exercise price granted        
Weighted average grant date fair value granted     ¥ 0.72    
Number of shares granted exercised (in Shares)        
Weighted average exercise price exercised        
Weighted average grant date fair value exercised        
Number of shares granted surrendered (in Shares)        
Weighted average exercise price surrendered        
Weighted average grant date fair value surrendered        
Share Incentive Plan 2020 [Member]              
Share-Based Compensation Expenses (Details) - Schedule of summary of share option activity [Line Items]              
Number of shares balance (in Shares)     119,674,780        
Weighted average exercise price balance            
Weighted average grant date fair value balance     ¥ 0.72        
Number of shares granted exercisable (in Shares)     59,837,390        
Weighted average exercise price exercisable            
Weighted average grant date fair value exercisable     ¥ 0.72        
Number of shares granted expected to vest (in Shares)     59,837,390        
Weighted average exercise price expected to vest            
Weighted average grant date fair value expected to vest     ¥ 0.72